Search research articles
Contact Us
Filters
Showing results (121-130 of 182) with videos related to
Page
of 19
Sort By:
BMC Cancer
|
June 5, 2026
The prognostic significance of B7-H3 expression in patients with advanced colorectal cancer
Yan Huang, Ana Acuna-Villaorduna, Radhika Gali, et al.
NPJ Precision Oncology
|
July 17, 2025
Multi-omic characterization of early-onset esophagogastric cancer
Lawrence W Wu, Sachin Kumar Deshmukh, Sharon Wu, et al.
Investigational New Drugs
|
July 3, 2009
Intravenous administration of Reolysin, a live replication competent RNA virus is safe in patients with advanced solid tumors
Radharani Gollamudi, Mohammad H Ghalib, Kavita K Desai, et al.
Cancers
|
May 26, 2018
A Phase II Study of Pelareorep (REOLYSIN<sup>®</sup>) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma
Devalingam Mahalingam, Sanjay Goel, Santiago Aparo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2009
A phase I study of eribulin mesylate (E7389), a mechanistically novel inhibitor of microtubule dynamics, in patients with advanced solid malignancies
Sanjay Goel, Alain C Mita, Monica Mita, et al.
Nature Cancer
|
October 18, 2021
Patterns of seroconversion for SARS-CoV2-IgG in patients with malignant disease and association with anticancer therapy
Astha Thakkar, Kith Pradhan, Shawn Jindal, et al.
Clinical Pharmacology in Drug Development
|
November 16, 2022
Effect of Pevonedistat, an Investigational NEDD8-Activating Enzyme Inhibitor, on the QTc Interval in Patients With Advanced Solid Tumors
Xiaofei Zhou, Debra L Richardson, Afshin Dowlati, et al.
British Journal of Haematology
|
June 2, 2020
A case series of Monoclonal Gammopathy of Undetermined Significance and COVID-19
Jesus D Gonzalez-Lugo, Lizamarie Bachier-Rodriguez, Mendel Goldfinger, et al.
Cancer Chemotherapy and Pharmacology
|
August 30, 2011
Phase I dose escalation study of KOS-1584, a novel epothilone, in patients with advanced solid tumors
Elaine T Lam, Sanjay Goel, Larry J Schaaf, et al.
Future Oncology (London, England)
|
February 11, 2022
Long-term avelumab in advanced non-small-cell lung cancer: summaries and <i>post hoc</i> analyses from JAVELIN Solid Tumor
Borys Hrinczenko, Nicholas Iannotti, Sanjay Goel, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 182) with videos related to
Sort By:
Page
of 19
BMC Cancer
|
June 5, 2026
The prognostic significance of B7-H3 expression in patients with advanced colorectal cancer
Yan Huang, Ana Acuna-Villaorduna, Radhika Gali, et al.
NPJ Precision Oncology
|
July 17, 2025
Multi-omic characterization of early-onset esophagogastric cancer
Lawrence W Wu, Sachin Kumar Deshmukh, Sharon Wu, et al.
Investigational New Drugs
|
July 3, 2009
Intravenous administration of Reolysin, a live replication competent RNA virus is safe in patients with advanced solid tumors
Radharani Gollamudi, Mohammad H Ghalib, Kavita K Desai, et al.
Cancers
|
May 26, 2018
A Phase II Study of Pelareorep (REOLYSIN<sup>®</sup>) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma
Devalingam Mahalingam, Sanjay Goel, Santiago Aparo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2009
A phase I study of eribulin mesylate (E7389), a mechanistically novel inhibitor of microtubule dynamics, in patients with advanced solid malignancies
Sanjay Goel, Alain C Mita, Monica Mita, et al.
Nature Cancer
|
October 18, 2021
Patterns of seroconversion for SARS-CoV2-IgG in patients with malignant disease and association with anticancer therapy
Astha Thakkar, Kith Pradhan, Shawn Jindal, et al.
Clinical Pharmacology in Drug Development
|
November 16, 2022
Effect of Pevonedistat, an Investigational NEDD8-Activating Enzyme Inhibitor, on the QTc Interval in Patients With Advanced Solid Tumors
Xiaofei Zhou, Debra L Richardson, Afshin Dowlati, et al.
British Journal of Haematology
|
June 2, 2020
A case series of Monoclonal Gammopathy of Undetermined Significance and COVID-19
Jesus D Gonzalez-Lugo, Lizamarie Bachier-Rodriguez, Mendel Goldfinger, et al.
Cancer Chemotherapy and Pharmacology
|
August 30, 2011
Phase I dose escalation study of KOS-1584, a novel epothilone, in patients with advanced solid tumors
Elaine T Lam, Sanjay Goel, Larry J Schaaf, et al.
Future Oncology (London, England)
|
February 11, 2022
Long-term avelumab in advanced non-small-cell lung cancer: summaries and <i>post hoc</i> analyses from JAVELIN Solid Tumor
Borys Hrinczenko, Nicholas Iannotti, Sanjay Goel, et al.
Page
of 19